Nexstim Plc

Helsinki Stock Exchange NXTMH.HE

Nexstim Plc Current Liabilities for the year ending December 31, 2023: USD 3.80 M

Nexstim Plc Current Liabilities is USD 3.80 M for the year ending December 31, 2023, a 0.48% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Nexstim Plc Current Liabilities for the year ending December 31, 2022 was USD 3.78 M, a -6.76% change year over year.
Nexstim Plc Current Liabilities for the year ending December 31, 2021 was USD 4.06 M, a -12.83% change year over year.
Nexstim Plc Current Liabilities for the year ending December 31, 2020 was USD 4.65 M, a 33.46% change year over year.
Nexstim Plc Current Liabilities for the year ending December 31, 2019 was USD 3.49 M, a 9.06% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Helsinki Stock Exchange: NXTMH.HE

Nexstim Plc

CEO	Mr. Mikko Karvinen
IPO Date	Nov. 14, 2014
Location	Finland
Headquarters	ElimAeenkatu 9 B
Employees	39
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.

Key trends

Past 5 years